Amgen’s legendary lawyer corps loses a major court fight attempting to quash PCSK9 rival from Sanofi, Regeneron
Sanofi and Regeneron may be losing the battle for sales of their PCSK9 drug Praluent in their fight against Amgen’s Repatha for market share — but they just won a badly needed victory on the legal front.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.